Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Brain Cancer|Brain Metastases|Melanoma|Lung Cancer|Breast Cancer|HER2-positive Breast Cancer|Colorectal Cancer|Gastrointestinal Cancer|SRS|SRT|Whole Brain Radiation|Stereotactic Radiation|AGuIX|Nanoparticle|Cystic|Brain Tumor
Interventions: RADIATION: Stereotactic Radiation|DRUG: AGuIX gadolinium-based nanoparticles|OTHER: Placebo
Sponsor: Dana-Farber Cancer Institute
Collaborators: NH TherAguix SAS